GnRH agonist for postpartum contraception: Biochemical, hormonal and endometrial effects

Abstract

Because GnRH agonist treatment had no significant deleterious effects on the parameters studied, this treatment could represent a feasible and safe approach to postpartum contraception.

GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial

“…The administration of high doses of GnRH agonists has been assessed as a feasible approach to contraception, even in the postpartum period (1)(2)(3). GnRH agonists have also been reported as a cause of abortion through their action on the corpus luteum (4).…”